Robinson, H. R., Qi, J., Cook, E. M., Nichols, C., Dadashian, E. L., Underbayev, C., . . . Wiestner, A. (2018). A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood.
Stile di citazione ChicagoRobinson, Hannah R., et al. "A CD19/CD3 Bispecific Antibody for Effective Immunotherapy of Chronic Lymphocytic Leukemia in the Ibrutinib Era." Blood 2018.
Citazione MLARobinson, Hannah R., et al. "A CD19/CD3 Bispecific Antibody for Effective Immunotherapy of Chronic Lymphocytic Leukemia in the Ibrutinib Era." Blood 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.